Product Information
MOXIFLOXACIN HCL 400 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $1.6263 per EA under NDC 72205000105. Its NADAC has been published 315 times since Nov 7, 2018.
FDA first approved this application on Sep 22, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205000105
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
10/23/2024
Active Ingredients
MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA208682FDA Approved
9/22/2017
TE Code
AB
On Market Since
7/21/2018
Pharmacological Classes
Price Statistics
The NADAC for MOXIFLOXACIN HCL 400 MG TABLET has been published 315 times since Nov 7, 2018, and over the history we have for it it has declined 47.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6263 per EA |
|---|---|
| All-time high | $3.4487 (Dec 12, 2018) |
| All-time low | $1.0251 (Nov 18, 2020) |
| Median price | $1.6180 |
| Average price | $1.6978 |
| Largest weekly change | +54.4% (Aug 19, 2020) |
| Weeks tracked | 315 |
| Tracking since | Nov 7, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-0.7%
5Y
+31.0%
All
-47.3%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MOXIFLOXACIN HCL 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MOXIFLOXACIN HCL 400 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $1.6263 per EA (NDC 72205000105), effective Nov 13, 2024.
How has the price of MOXIFLOXACIN HCL 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for MOXIFLOXACIN HCL 400 MG TABLET has declined 47.3%. It has been tracked across 315 weekly CMS publications since Nov 7, 2018.
What are the highest and lowest recorded NADAC prices for MOXIFLOXACIN HCL 400 MG TABLET?
Since Nov 7, 2018, the NADAC for MOXIFLOXACIN HCL 400 MG TABLET has ranged from a low of $1.0251 (Nov 18, 2020) to a high of $3.4487 (Dec 12, 2018), with a median of $1.6180 per EA.
Are there cheaper alternatives to MOXIFLOXACIN HCL 400 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MOXIFLOXACIN HCL 400 MG TABLET, is $1.3428 per EA — about 17% below MOXIFLOXACIN HCL 400 MG TABLET.
Who manufactures MOXIFLOXACIN HCL 400 MG TABLET?
MOXIFLOXACIN HCL 400 MG TABLET (NDC 72205000105) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.